Targeting liver metabolism: a pathway to cure hepatitis B virus?

Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(7):645-647. doi: 10.1080/17474124.2023.2226390. Epub 2023 Jun 18.

Authors

Harout Ajoyan¹, Mark W Douglas^{1

2}, Thomas Tu^{1

2}

Affiliations

¹ Storr Liver Centre, the Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead, NSW, Australia.
² Centre for Infectious Diseases and Microbiology, Sydney Infectious Diseases Institute, The University of Sydney at Westmead Hospital, Westmead, NSW, Australia.

PMID: 37318059
DOI: 10.1080/17474124.2023.2226390

No abstract available

Keywords: Antiviral; functional cure; host-targeting therapies; subviral particles; viral hepatitis.

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use
DNA, Viral
Hepatitis B Surface Antigens
Hepatitis B virus / genetics
Hepatitis B* / diagnosis
Hepatitis B* / drug therapy
Hepatitis B, Chronic* / drug therapy
Humans

Substances

Antiviral Agents
Hepatitis B Surface Antigens
DNA, Viral